Joakim Tedroff

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

Justo García de Yébenes, G. Bernhard Landwehrmeyer, Ferdinando Squitieri et al. · The Lancet Neurology · 2011 · 171 citations

Degenerative Disease, Neuropharmacology, Placebo-controlled Trial +8

Levodopa‐induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [¹¹C]raclopride displacement and PET

Joakim Tedroff, Marie Pedersen, Aquilonius Sm et al. · Neurology · 1996 · 162 citations

Manganese induced brain lesions inMacaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging

Håkan Eriksson, Joakim Tedroff, Karl‐Åke Thuomas et al. · Archives of Toxicology · 1992 · 132 citations

Positron Emission Tomography, Brain Lesions, Neuroanatomy +12

Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers

Klaus L. Leenders, Sten‐Magnus Aquilonius, K Bergström et al. · Brain Research · 1988 · 106 citations

Rhesus Monkey, Striatal Dopaminergic System, Neurophysiology +12

Low brain uptake of L‐[¹¹C]5‐hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers

Hans Ågren, L. Reibring, Per Hartvig et al. · Acta Psychiatrica Scandinavica · 1991 · 93 citations